logo
[breadcrumb_custom]

Tag: Moderna Inc. (NASDAQ:MRNA)

Stock

A Tale of Resilience: Moderna Inc Amid Stock Market Turbulence

Moderna Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $163.24 on 04/14/23, and the lowest price during that time was $62.55, recorded on 11/02/23. 52-week price history of MRNA Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Moderna Inc’s current trading price is -37.40% away from its 52-week high, while its distance from the 52-week low is 63.36%. The stock’s price range during this period has fluctuated between $62.55 and $163.24. Shares of the company, which operates in the

ELVT Stock
Stock

A Closer Look at Moderna Inc (MRNA) Stock Gains

Moderna Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $163.24 on 04/14/23 and the lowest value was $62.55 on 11/02/23. 52-week price history of MRNA Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Moderna Inc’s current trading price is -31.36% away from its 52-week high, while its distance from the 52-week low is 79.14%. The stock’s price range during the 52-week period has remained between $62.55 and $163.24. In the Healthcare sector, the company’s

Stock

Moderna Inc (MRNA) Stock: A Year of Declines and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Moderna Inc’s current trading price is -39.90% away from its 52-week high, while its distance from the 52-week low is 56.83%. The stock’s price range for this period has been between $62.55 and $163.24 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.32 million for the day, a number notably lower than the average daily volume of 5.05 million over the last three months. Moderna Inc’s market performance has been unstable in

Industry

The Role of News and Events in Moderna Inc Inc. (MRNA) Price Performance

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -0.90%.However, over the last six months, we can see a stronger performance of -13.42%. Over the last 30 days, the price of MRNA has leaped by -6.00%. And in the last five days, it has surged by 12.51%. Moderna Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $163.24 on 04/14/23, with

Industry

Moderna Inc (MRNA) Stock: A Year of Stock Market Ups and Downs

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Moderna Inc’s current trading price is -47.51% away from its 52-week high, while its distance from the 52-week low is 40.03%. The stock’s price range for this time frame has been between $62.55 and $166.86. The trading volume of the company’s shares in the Healthcare reached around 3.75 million for the day, which was evidently lower than the average daily volume of 4.75 million over the last three months. In terms of market performance, Moderna Inc had a somewhat

CROX
Finance

Moderna Inc (MRNA) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Moderna Inc’s current trading price is -50.72% away from its 52-week high, while its distance from the 52-week low is 39.74%. The stock’s price range over this period has fluctuated between $62.55 and $177.37. The company, operating within the financial sector, had a trading volume of approximately 4.64 for the day, which was noticeably higher than the average daily share volume of 1.55 over the last 3 months. In terms of market performance, Moderna Inc had a

News

Moderna Inc (MRNA) Stock: Uncovering a 52-Week Range and Trading Volume

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Moderna Inc’s current trading price is -44.94% away from its 52-week high, while its distance from the 52-week low is 56.13%. The stock’s price range for this time frame has been between $62.55 and $177.37. The trading volume of the company’s shares in the Healthcare reached around 0.92 million for the day, which was evidently lower than the average daily volume of 4.64 million over the last three months. Moderna Inc’s stock has had a tumultuous market performance. The

Stock

Moderna Inc (MRNA) Stock: Navigating a Year of Volatility

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Moderna Inc’s current trading price is -45.44% away from its 52-week high, while its distance from the 52-week low is 55.90%. The stock’s price range for this period has been between $62.55 and $178.74 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.28 million for the day, a number notably lower than the average daily volume of 5.03 million over the last three months. Moderna Inc ‘s stock market performance has been

Finance

Moderna Inc (MRNA) Stock: A Year of Market Fluctuations

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Moderna Inc’s current trading price is -47.87% away from its 52-week high, while its distance from the 52-week low is 64.22%. The stock’s price range over this period has fluctuated between $62.55 and $197.06. The company, operating within the financial sector, had a trading volume of approximately 1.01 million for the day, which was noticeably lower than the average daily share volume of 5.16 million over the last 3 months. Moderna Inc’s market performance has been unstable